A look at key investment strategies and performance reviews, from the 60/40 portfolio debate to individual stock assessments and fund analyses, offering insights for Q2 2024. Read more...
A look at the new market volatility regime, Apple's upcoming iPhone 16e and its stock implications, plus key takeaways from recent earnings calls for Atea Pharmaceuticals and Methode Electronics. Read more...